ALFA FinderBSE filing, NSE: MOREPENLAB. Summary written from the filing by ALFA Finder's alert engine.
Morepen Laboratories Ltd: key numbers
- Share price
- ₹99.64
- Market cap
- ₹5,460 Cr
- Revenue (annual)
- ₹1,806 Cr
- Net profit (annual)
- ₹94.88 Cr
- P/E (TTM)
- 29.0×Sector 43.7×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 3.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Morepen Laboratories Ltd
All →Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
Morepen Laboratories Management Change
Morepen Laboratories announced promotions effective 27 October 2026 for two senior management personnel. Charanjeet Chitakara moves to Assistant Vice President (Quality Control) and Vivan Prashar to Vice President (Projects & Engineering).
Morepen Laboratories Other Announcement
Morepen filed its Q2FY27 Monitoring Agency Report confirming Nil deviation in QIP proceeds utilization. The company spent ₹1.12 crore on modernization and expansion during the quarter.
Morepen Laboratories Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs755 Cr (+81%), PAT Rs89 Cr (+117%), EBITDA margin 17.45% (+897bps). H1 revenue Rs1,330 Cr (+57%). CDMO scale-up drives mix.
Morepen Laboratories Results Update
Morepen hit record Q2 FY27 revenue up 81% and EBITDA up 273%, driven by CDMO scale-up. H1 EBITDA reached ₹220 Cr; API+CDMO capacity now 614 KL.
- API + CDMO manufacturing capacity
- 614 KL
Morepen Laboratories Q2 FY27 Results: Net Profit ₹88.9 Cr, Up 117.4% YoY
Morepen Laboratories Ltd reported revenue from operations of ₹746.5 Cr (+81.4% YoY) and net profit of ₹88.9 Cr (+117.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹88.9 Cr · +117.4% YoY
Other credit rating announcements
All →Sai Life Science Credit Rating
Sai Life Sciences disclosed that India Ratings upgraded its bank loan facilities of INR 7,690 million to 'IND AA' from 'IND AA-' with Stable outlook. Short-term rating was affirmed at 'IND A1+'.
Juniper Green Energy Credit Rating
Ind-Ra withdrew Juniper Green Energy's rating after full repayment of its IREDA term loan. No new financing or fresh money is involved.
PVR INOX Credit Rating
India Ratings revised PVR INOX's bank loan outlook to Positive from Stable, affirming IND AA. The outlook reflects improved profitability, lower debt and stronger credit metrics.
Vishal Nirmiti Credit Rating
Vishal Nirmiti's bank facilities were upgraded to IVR BBB+/Stable by Infomerics, with short-term rating raised to IVR A2. Total rated bank loan facilities were reduced to Rs 115 Crore.
Birla Corporation Credit Rating
Birla Corporation's bank facilities were reaffirmed at CARE AA, Stable by CARE Ratings. Its NCD ratings were withdrawn after full redemption.
E2E Networks Credit Rating
ICRA upgraded E2E Networks' bank facility rating to [ICRA] A (Positive) from [ICRA] A- (Stable), covering Rs. 1,000 crore of facilities. The rating reflects strong H1 FY2027 revenue growth and GPU utilisation.